Alzheimers Research UK logo

Future Of Dementia Medicines Discussed At University Of Bradford

Alzheimers-Research-UK-logoYorkshire scientists are inviting the public to a free meeting in Bradford on 10 December, to discuss current dementia research. The meeting will include a series of talks from experts, sharing the latest research developments towards treatments for dementia.

The meeting is organised by the Alzheimer’s Research UK Yorkshire Research Network, a community of scientists across the region working to defeat dementia.

Alzheimer’s Research UK is the UK’s leading dementia research charity, funding research into the causes of dementia, diagnosis, preventions and treatments. They currently fund more than £26 million of dementia research across the UK and have recently invested in a unique Drug Discovery Alliance, to accelerate the hunt for new treatments for the disease that cause dementia.

The public meeting, which is being hosted by Bradford School of Pharmacy, takes place on Thursday 10 December in the Richmond building at the University of Bradford, 2.30-4.45pm. ‘Horizons in Medicines Discovery for Dementia’ will bring together experts from across the UK. This includes a talk from Prof Murna Downs, Head of the School of Dementia Studies, who will be speaking about dementia care. The University has just been awarded a coveted Queen’s Anniversary Prize for Higher and Further Education for its world-leading work to improve the lives of people living with dementia.

Also speaking at the event will be Prof Paul Whiting, Chief Scientific Officer at the Alzheimer’s Research UK University College London Drug Discovery Institute, on drug discovery in Alzheimer’s disease. Joining him will be Prof Joe Sweeney from the University of Huddersfield, looking at challenges in the development of drugs that can protect nerve cells from damage.

Prof Marcus Rattray, Head of Bradford School of Pharmacy, said:

“This promises to be an interesting event, exploring the cutting edge techniques that researchers across the UK are using in drug discovery and dementia care and highlighting some of the exciting research that is being carried out in the Yorkshire area to improve the lives of people living with dementia.”

Dr Emma O’Brien from Alzheimer’s Research UK, said:

“There have been no new treatments licensed for Alzheimer’s since 2002 and many people with other causes of dementia have no specific treatments available to them. It is vital that we invest in research that takes us closer to treatments to help the 850,000 people living with dementia in the UK, including over 5,500 in Bradford alone. This meeting will be a fantastic opportunity to learn more about the latest research developments across Yorkshire and beyond.”

Tickets are free, and can be reserved here





COTS 2024